Ascent Solar (ASTI) Gets Registered Direct Financing, Mechel (MTL) Selling Stake in Vanino Sea Trade Port OAO
CryoLife (NYSE:CRY) Q3 Solid Financial Performance, Baxano Surgical (Nasdaq:BAXS) Patent Issuance
Oncolytics Biotech (ONCY) Positive Data On Its Proprietary Formulation of the Human Reovirus
Oncolytics Biotech Inc. (Nasdaq:ONCY)
ONCY reported a poster presentation containing updated efficacy data from a Phase 2 study examining the use of its proprietary formulation of the human reovirus REOLYSIN(R), in combination with carboplatin and paclitaxel in patients with stage IV non-small cell lung cancer with Kras or EGFR-activated tumors (REO 016) was made at International Association for the Study of Lung Cancer.